Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$66.47 - $69.65 $44.6 Million - $46.8 Million
-671,388 Reduced 66.05%
345,071 $23.2 Million
Q1 2024

May 13, 2024

BUY
$56.67 - $69.36 $36.5 Million - $44.6 Million
643,550 Added 172.58%
1,016,459 $70.1 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $11.1 Million - $14.3 Million
224,876 Added 151.91%
372,909 $23.2 Million
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $4.63 Million - $5.95 Million
95,244 Added 180.42%
148,033 $8.31 Million
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $68,145 - $85,498
-1,420 Reduced 2.62%
52,789 $2.66 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $2.85 Million - $3.65 Million
54,209 New
54,209 $2.96 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $7.08 Million - $11.5 Million
179,140 Added 87.18%
384,625 $21.8 Million
Q1 2022

May 16, 2022

SELL
$43.74 - $62.76 $17.7 Million - $25.4 Million
-404,863 Reduced 66.33%
205,485 $12.9 Million
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $30.5 Million - $44.8 Million
610,348 New
610,348 $34.2 Million
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $19.2 Million - $25.6 Million
-325,064 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$51.39 - $66.9 $3.36 Million - $4.37 Million
-65,361 Reduced 16.74%
325,064 $20.6 Million
Q1 2021

May 17, 2021

BUY
$49.14 - $59.89 $19.2 Million - $23.4 Million
390,425 New
390,425 $23.4 Million
Q3 2020

Nov 16, 2020

SELL
$35.33 - $51.04 $5.62 Million - $8.12 Million
-159,024 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $3.64 Million - $6.33 Million
159,024 New
159,024 $5.58 Million
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $7.53 Million - $17.3 Million
-458,042 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $8.96 Million - $13.3 Million
458,042 New
458,042 $12.7 Million
Q3 2019

Nov 14, 2019

SELL
$26.92 - $42.41 $694,859 - $1.09 Million
-25,812 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$18.54 - $40.97 $478,554 - $1.06 Million
25,812 New
25,812 $1.06 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.